Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Certified by Founder
Lodge
ZBiotics
start up
United States
- San Francisco, California
- 28/08/2024
- Series A
- $12,000,000
Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. Our first product is a probiotic that helps you feel better the day after drinking alcohol.
ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way.
It’s genetic engineering as it should be: transparent, responsible, and people first.
- Industry Biotechnology Research
- Website https://zbiotics.com/
- LinkedIn https://www.linkedin.com/company/zbiotics/
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)